3D Printing Technology in Design of Pharmaceutical Products

Ameeduzzafar, Nabil K. Alruwaili, Md Rizwanullah, Bukhari Syed Nasir Abbas, Mohd Amir, Muhammad Masood Ahmed, Mohammad Fazil

Research output: Contribution to journalArticle

Abstract

BACKGROUND: Three-dimensional printing (3DP) is a novel technology for fabrication of personalized medicine. As of late, FDA affirmed 3D printed tranquilize item in August 2015, which is characteristic of another section of Pharmaceutical assembling. 3DP incorporates a wide range of assembling procedures, which are altogether founded on computer-aided design (CAD), and controlled deposition of materials (layer-by-layer) to make freestyle geometries. Conventionally, many pharmaceutical processes like compressed tablet have been used from many years for the development of tablet with established regulatory pathways. But this simple process is outdated in terms of process competence and manufacturing flexibility (design space). 3DP is a new technology for the creation of plan, proving to be superior for complex products, customized items and items made on-request. It creates new opportunities for improving efficacy, safety, and convenience of medicines. METHOD: There are many of the 3D printing technology used for the development of personalized medicine on demand for better treatment like 3D powder direct printing technology, fused-filament 3D printing, 3D extrusion printer, piezoelectric inkjet printer, fused deposition 3D printing, 3D printer, ink-jet printer, micro-drop inkjet 3DP, thermal inkjet printer, multi-nozzle 3D printer, stereolithographic 3D printer. RESULT: This review highlights features how item and process comprehension can encourage the improvement of a control technique for various 3D printing strategies. CONCLUSION: It is concluded that the 3D printing technology is a novel potential for manufacturing of personalized dose medicines, due to better patient compliance which can be prepared when needed.

Original languageEnglish
Pages (from-to)5009-5018
Number of pages10
JournalCurrent pharmaceutical design
Volume24
Issue number42
DOIs
Publication statusPublished - 1 Jan 2018
Externally publishedYes

Fingerprint

Technology
Pharmaceutical Preparations
Precision Medicine
Tablets
Three Dimensional Printing
Computer-Aided Design
Printing
Ink
Patient Compliance
Powders
Mental Competency
Hot Temperature
Safety

Keywords

  • complex products
  • computer-aided design
  • efficacy
  • layer-by-layer
  • personalized medicine.
  • Three-dimensional printing

ASJC Scopus subject areas

  • Pharmacology
  • Drug Discovery

Cite this

Ameeduzzafar, Alruwaili, N. K., Rizwanullah, M., Syed Nasir Abbas, B., Amir, M., Ahmed, M. M., & Fazil, M. (2018). 3D Printing Technology in Design of Pharmaceutical Products. Current pharmaceutical design, 24(42), 5009-5018. https://doi.org/10.2174/1381612825666190116104620

3D Printing Technology in Design of Pharmaceutical Products. / Ameeduzzafar; Alruwaili, Nabil K.; Rizwanullah, Md; Syed Nasir Abbas, Bukhari; Amir, Mohd; Ahmed, Muhammad Masood; Fazil, Mohammad.

In: Current pharmaceutical design, Vol. 24, No. 42, 01.01.2018, p. 5009-5018.

Research output: Contribution to journalArticle

Ameeduzzafar, Alruwaili, NK, Rizwanullah, M, Syed Nasir Abbas, B, Amir, M, Ahmed, MM & Fazil, M 2018, '3D Printing Technology in Design of Pharmaceutical Products', Current pharmaceutical design, vol. 24, no. 42, pp. 5009-5018. https://doi.org/10.2174/1381612825666190116104620
Ameeduzzafar ; Alruwaili, Nabil K. ; Rizwanullah, Md ; Syed Nasir Abbas, Bukhari ; Amir, Mohd ; Ahmed, Muhammad Masood ; Fazil, Mohammad. / 3D Printing Technology in Design of Pharmaceutical Products. In: Current pharmaceutical design. 2018 ; Vol. 24, No. 42. pp. 5009-5018.
@article{03571b2989a74c7f80c45e0852241b6c,
title = "3D Printing Technology in Design of Pharmaceutical Products",
abstract = "BACKGROUND: Three-dimensional printing (3DP) is a novel technology for fabrication of personalized medicine. As of late, FDA affirmed 3D printed tranquilize item in August 2015, which is characteristic of another section of Pharmaceutical assembling. 3DP incorporates a wide range of assembling procedures, which are altogether founded on computer-aided design (CAD), and controlled deposition of materials (layer-by-layer) to make freestyle geometries. Conventionally, many pharmaceutical processes like compressed tablet have been used from many years for the development of tablet with established regulatory pathways. But this simple process is outdated in terms of process competence and manufacturing flexibility (design space). 3DP is a new technology for the creation of plan, proving to be superior for complex products, customized items and items made on-request. It creates new opportunities for improving efficacy, safety, and convenience of medicines. METHOD: There are many of the 3D printing technology used for the development of personalized medicine on demand for better treatment like 3D powder direct printing technology, fused-filament 3D printing, 3D extrusion printer, piezoelectric inkjet printer, fused deposition 3D printing, 3D printer, ink-jet printer, micro-drop inkjet 3DP, thermal inkjet printer, multi-nozzle 3D printer, stereolithographic 3D printer. RESULT: This review highlights features how item and process comprehension can encourage the improvement of a control technique for various 3D printing strategies. CONCLUSION: It is concluded that the 3D printing technology is a novel potential for manufacturing of personalized dose medicines, due to better patient compliance which can be prepared when needed.",
keywords = "complex products, computer-aided design, efficacy, layer-by-layer, personalized medicine., Three-dimensional printing",
author = "Ameeduzzafar and Alruwaili, {Nabil K.} and Md Rizwanullah and {Syed Nasir Abbas}, Bukhari and Mohd Amir and Ahmed, {Muhammad Masood} and Mohammad Fazil",
year = "2018",
month = "1",
day = "1",
doi = "10.2174/1381612825666190116104620",
language = "English",
volume = "24",
pages = "5009--5018",
journal = "Current Pharmaceutical Design",
issn = "1381-6128",
publisher = "Bentham Science Publishers B.V.",
number = "42",

}

TY - JOUR

T1 - 3D Printing Technology in Design of Pharmaceutical Products

AU - Ameeduzzafar,

AU - Alruwaili, Nabil K.

AU - Rizwanullah, Md

AU - Syed Nasir Abbas, Bukhari

AU - Amir, Mohd

AU - Ahmed, Muhammad Masood

AU - Fazil, Mohammad

PY - 2018/1/1

Y1 - 2018/1/1

N2 - BACKGROUND: Three-dimensional printing (3DP) is a novel technology for fabrication of personalized medicine. As of late, FDA affirmed 3D printed tranquilize item in August 2015, which is characteristic of another section of Pharmaceutical assembling. 3DP incorporates a wide range of assembling procedures, which are altogether founded on computer-aided design (CAD), and controlled deposition of materials (layer-by-layer) to make freestyle geometries. Conventionally, many pharmaceutical processes like compressed tablet have been used from many years for the development of tablet with established regulatory pathways. But this simple process is outdated in terms of process competence and manufacturing flexibility (design space). 3DP is a new technology for the creation of plan, proving to be superior for complex products, customized items and items made on-request. It creates new opportunities for improving efficacy, safety, and convenience of medicines. METHOD: There are many of the 3D printing technology used for the development of personalized medicine on demand for better treatment like 3D powder direct printing technology, fused-filament 3D printing, 3D extrusion printer, piezoelectric inkjet printer, fused deposition 3D printing, 3D printer, ink-jet printer, micro-drop inkjet 3DP, thermal inkjet printer, multi-nozzle 3D printer, stereolithographic 3D printer. RESULT: This review highlights features how item and process comprehension can encourage the improvement of a control technique for various 3D printing strategies. CONCLUSION: It is concluded that the 3D printing technology is a novel potential for manufacturing of personalized dose medicines, due to better patient compliance which can be prepared when needed.

AB - BACKGROUND: Three-dimensional printing (3DP) is a novel technology for fabrication of personalized medicine. As of late, FDA affirmed 3D printed tranquilize item in August 2015, which is characteristic of another section of Pharmaceutical assembling. 3DP incorporates a wide range of assembling procedures, which are altogether founded on computer-aided design (CAD), and controlled deposition of materials (layer-by-layer) to make freestyle geometries. Conventionally, many pharmaceutical processes like compressed tablet have been used from many years for the development of tablet with established regulatory pathways. But this simple process is outdated in terms of process competence and manufacturing flexibility (design space). 3DP is a new technology for the creation of plan, proving to be superior for complex products, customized items and items made on-request. It creates new opportunities for improving efficacy, safety, and convenience of medicines. METHOD: There are many of the 3D printing technology used for the development of personalized medicine on demand for better treatment like 3D powder direct printing technology, fused-filament 3D printing, 3D extrusion printer, piezoelectric inkjet printer, fused deposition 3D printing, 3D printer, ink-jet printer, micro-drop inkjet 3DP, thermal inkjet printer, multi-nozzle 3D printer, stereolithographic 3D printer. RESULT: This review highlights features how item and process comprehension can encourage the improvement of a control technique for various 3D printing strategies. CONCLUSION: It is concluded that the 3D printing technology is a novel potential for manufacturing of personalized dose medicines, due to better patient compliance which can be prepared when needed.

KW - complex products

KW - computer-aided design

KW - efficacy

KW - layer-by-layer

KW - personalized medicine.

KW - Three-dimensional printing

UR - http://www.scopus.com/inward/record.url?scp=85064560419&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85064560419&partnerID=8YFLogxK

U2 - 10.2174/1381612825666190116104620

DO - 10.2174/1381612825666190116104620

M3 - Article

VL - 24

SP - 5009

EP - 5018

JO - Current Pharmaceutical Design

JF - Current Pharmaceutical Design

SN - 1381-6128

IS - 42

ER -